(1)連結財政状態計算書

(単位:百万円)

 

 

前連結会計年度
(2024年3月31日)

 

当連結会計年度
(2025年3月31日)

資産

 

 

 

 

流動資産

 

 

 

 

現金及び現金同等物

 

217,449

 

209,838

営業債権及びその他の債権

 

620,022

 

593,836

その他の金融資産

 

31,338

 

45,015

棚卸資産

 

709,637

 

625,243

その他の流動資産

 

79,077

 

49,993

小計

 

1,657,523

 

1,523,925

売却目的で保有する資産

 

18,359

 

59,209

流動資産合計

 

1,675,882

 

1,583,134

非流動資産

 

 

 

 

有形固定資産

 

796,526

 

759,266

のれん

 

263,757

 

257,811

無形資産

 

272,921

 

239,319

持分法で会計処理されている
投資

 

319,988

 

287,977

その他の金融資産

 

412,747

 

177,405

退職給付に係る資産

 

110,390

 

72,618

繰延税金資産

 

37,070

 

34,608

その他の非流動資産

 

45,537

 

27,646

非流動資産合計

 

2,258,936

 

1,856,650

資産合計

 

3,934,818

 

3,439,784

 

 

 

 

 

 

 

(単位:百万円)

 

 

前連結会計年度
(2024年3月31日)

 

当連結会計年度
(2025年3月31日)

負債及び資本

 

 

 

 

負債

 

 

 

 

流動負債

 

 

 

 

社債及び借入金

 

585,905

 

252,892

営業債務及びその他の債務

 

543,384

 

488,132

その他の金融負債

 

77,610

 

81,364

未払法人所得税等

 

8,545

 

10,627

引当金

 

90,919

 

89,711

その他の流動負債

 

129,087

 

109,360

小計

 

1,435,450

 

1,032,086

売却目的で保有する資産に
直接関連する負債

 

8,037

 

6,661

流動負債合計

 

1,443,487

 

1,038,747

非流動負債

 

 

 

 

社債及び借入金

 

977,581

 

1,033,236

その他の金融負債

 

100,144

 

91,157

退職給付に係る負債

 

30,589

 

24,841

引当金

 

46,059

 

25,974

繰延税金負債

 

121,146

 

111,048

その他の非流動負債

 

51,446

 

40,366

非流動負債合計

 

1,326,965

 

1,326,622

負債合計

 

2,770,452

 

2,365,369

資本

 

 

 

 

資本金

 

89,938

 

90,059

資本剰余金

 

237

 

利益剰余金

 

578,175

 

640,611

自己株式

 

8,355

 

8,361

その他の資本の構成要素

 

304,033

 

174,871

売却目的で保有する資産に関連する
その他の包括利益

 

1,725

 

3,610

親会社の所有者に帰属する持分
合計

 

965,753

 

900,790

非支配持分

 

198,613

 

173,625

資本合計

 

1,164,366

 

1,074,415

負債及び資本合計

 

3,934,818

 

3,439,784

 

 

 

 

 

 

 

E00752 40050 住友化学株式会社 SUMITOMO CHEMICAL COMPANY, LIMITED 通期第3号参考様式 [IFRS](連結) IFRS true cte cte 2024-04-01 2025-03-31 FY 2025-03-31 2023-04-01 2024-03-31 2024-03-31 1 false false false 40050 2025-05-14 40050 2024-04-01 2025-03-31 40050 2024-04-01 2025-03-31 jpigp_cor:CapitalSurplusIFRSMember 40050 2024-04-01 2025-03-31 jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember 40050 2024-04-01 2025-03-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 40050 2024-04-01 2025-03-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 40050 2024-04-01 2025-03-31 jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 40050 2024-04-01 2025-03-31 jpigp_cor:NonControllingInterestsIFRSMember 40050 2024-04-01 2025-03-31 jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember 40050 2024-04-01 2025-03-31 jpigp_cor:OtherComponentsOfEquityIFRSMember 40050 2024-04-01 2025-03-31 jpcrp_cor:ReconcilingItemsMember 40050 2024-04-01 2025-03-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 40050 2024-04-01 2025-03-31 jpcrp_cor:ReportableSegmentsMember 40050 2024-04-01 2025-03-31 jpigp_cor:RetainedEarningsIFRSMember 40050 2024-04-01 2025-03-31 jpigp_cor:ShareCapitalIFRSMember 40050 2024-04-01 2025-03-31 jpigp_cor:TreasurySharesIFRSMember 40050 2024-04-01 2025-03-31 tse-acediffr-40050:EnergyAndFunctionalMaterialsReportableSegmentMember 40050 2024-04-01 2025-03-31 tse-acediffr-40050:EssentialChemicalsAndPlasticsReportableSegmentMember 40050 2024-04-01 2025-03-31 tse-acediffr-40050:HealthAndAgricultureRelatedReportableSegmentMember 40050 2024-04-01 2025-03-31 tse-acediffr-40050:InformationElectronicChemistryReportableSegmentMember 40050 2024-04-01 2025-03-31 tse-acediffr-40050:MedicalProductsReportableSegmentMember 40050 2024-04-01 2025-03-31 tse-acediffr-40050:OtherComprehensiveIncomeRelatedToAssetsHeldForSaleIFRSMember 40050 2025-03-31 40050 2025-03-31 jpigp_cor:CapitalSurplusIFRSMember 40050 2025-03-31 jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember 40050 2025-03-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 40050 2025-03-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 40050 2025-03-31 jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 40050 2025-03-31 jpigp_cor:NonControllingInterestsIFRSMember 40050 2025-03-31 jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember 40050 2025-03-31 jpigp_cor:OtherComponentsOfEquityIFRSMember 40050 2025-03-31 jpcrp_cor:ReconcilingItemsMember 40050 2025-03-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 40050 2025-03-31 jpcrp_cor:ReportableSegmentsMember 40050 2025-03-31 jpigp_cor:RetainedEarningsIFRSMember 40050 2025-03-31 jpigp_cor:ShareCapitalIFRSMember 40050 2025-03-31 jpigp_cor:TreasurySharesIFRSMember 40050 2025-03-31 tse-acediffr-40050:EnergyAndFunctionalMaterialsReportableSegmentMember 40050 2025-03-31 tse-acediffr-40050:EssentialChemicalsAndPlasticsReportableSegmentMember 40050 2025-03-31 tse-acediffr-40050:HealthAndAgricultureRelatedReportableSegmentMember 40050 2025-03-31 tse-acediffr-40050:InformationElectronicChemistryReportableSegmentMember 40050 2025-03-31 tse-acediffr-40050:MedicalProductsReportableSegmentMember 40050 2025-03-31 tse-acediffr-40050:OtherComprehensiveIncomeRelatedToAssetsHeldForSaleIFRSMember 40050 2023-04-01 2024-03-31 40050 2023-04-01 2024-03-31 jpigp_cor:CapitalSurplusIFRSMember 40050 2023-04-01 2024-03-31 jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember 40050 2023-04-01 2024-03-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 40050 2023-04-01 2024-03-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 40050 2023-04-01 2024-03-31 jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 40050 2023-04-01 2024-03-31 jpigp_cor:NonControllingInterestsIFRSMember 40050 2023-04-01 2024-03-31 jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember 40050 2023-04-01 2024-03-31 jpigp_cor:OtherComponentsOfEquityIFRSMember 40050 2023-04-01 2024-03-31 jpcrp_cor:ReconcilingItemsMember 40050 2023-04-01 2024-03-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 40050 2023-04-01 2024-03-31 jpcrp_cor:ReportableSegmentsMember 40050 2023-04-01 2024-03-31 jpigp_cor:RetainedEarningsIFRSMember 40050 2023-04-01 2024-03-31 jpigp_cor:ShareCapitalIFRSMember 40050 2023-04-01 2024-03-31 jpigp_cor:TreasurySharesIFRSMember 40050 2023-04-01 2024-03-31 tse-acediffr-40050:EnergyAndFunctionalMaterialsReportableSegmentMember 40050 2023-04-01 2024-03-31 tse-acediffr-40050:EssentialChemicalsAndPlasticsReportableSegmentMember 40050 2023-04-01 2024-03-31 tse-acediffr-40050:HealthAndAgricultureRelatedReportableSegmentMember 40050 2023-04-01 2024-03-31 tse-acediffr-40050:InformationElectronicChemistryReportableSegmentMember 40050 2023-04-01 2024-03-31 tse-acediffr-40050:MedicalProductsReportableSegmentMember 40050 2023-04-01 2024-03-31 tse-acediffr-40050:OtherComprehensiveIncomeRelatedToAssetsHeldForSaleIFRSMember 40050 2024-03-31 40050 2024-03-31 jpigp_cor:CapitalSurplusIFRSMember 40050 2024-03-31 jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember 40050 2024-03-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 40050 2024-03-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 40050 2024-03-31 jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 40050 2024-03-31 jpigp_cor:NonControllingInterestsIFRSMember 40050 2024-03-31 jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember 40050 2024-03-31 jpigp_cor:OtherComponentsOfEquityIFRSMember 40050 2024-03-31 jpcrp_cor:ReconcilingItemsMember 40050 2024-03-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 40050 2024-03-31 jpcrp_cor:ReportableSegmentsMember 40050 2024-03-31 jpigp_cor:RetainedEarningsIFRSMember 40050 2024-03-31 jpigp_cor:ShareCapitalIFRSMember 40050 2024-03-31 jpigp_cor:TreasurySharesIFRSMember 40050 2024-03-31 tse-acediffr-40050:EnergyAndFunctionalMaterialsReportableSegmentMember 40050 2024-03-31 tse-acediffr-40050:EssentialChemicalsAndPlasticsReportableSegmentMember 40050 2024-03-31 tse-acediffr-40050:HealthAndAgricultureRelatedReportableSegmentMember 40050 2024-03-31 tse-acediffr-40050:InformationElectronicChemistryReportableSegmentMember 40050 2024-03-31 tse-acediffr-40050:MedicalProductsReportableSegmentMember 40050 2024-03-31 tse-acediffr-40050:OtherComprehensiveIncomeRelatedToAssetsHeldForSaleIFRSMember 40050 2023-03-31 40050 2023-03-31 jpigp_cor:CapitalSurplusIFRSMember 40050 2023-03-31 jpigp_cor:EffectivePortionOfCashFlowHedgesIFRSMember 40050 2023-03-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 40050 2023-03-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 40050 2023-03-31 jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 40050 2023-03-31 jpigp_cor:NonControllingInterestsIFRSMember 40050 2023-03-31 jpigp_cor:OtherComponentsOfEquityIFRSMember 40050 2023-03-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 40050 2023-03-31 jpigp_cor:RetainedEarningsIFRSMember 40050 2023-03-31 jpigp_cor:ShareCapitalIFRSMember 40050 2023-03-31 jpigp_cor:TreasurySharesIFRSMember 40050 2023-03-31 tse-acediffr-40050:OtherComprehensiveIncomeRelatedToAssetsHeldForSaleIFRSMember iso4217:JPY iso4217:JPY xbrli:shares xbrli:pure